SARS-CoV-2 Proteins Interact with Alpha Synuclein and Induce Lewy Body-like Pathology In Vitro
- PMID: 35328814
- PMCID: PMC8949667
- DOI: 10.3390/ijms23063394
SARS-CoV-2 Proteins Interact with Alpha Synuclein and Induce Lewy Body-like Pathology In Vitro
Abstract
Growing cases of patients reported have shown a potential relationship between (severe acute respiratory syndrome coronavirus 2) SARS-CoV-2 infection and Parkinson's disease (PD). However, it is unclear whether there is a molecular link between these two diseases. Alpha-synuclein (α-Syn), an aggregation-prone protein, is considered a crucial factor in PD pathology. In this study, bioinformatics analysis confirmed favorable binding affinity between α-Syn and SARS-CoV-2 spike (S) protein and nucleocapsid (N) protein, and direct interactions were further verified in HEK293 cells. The expression of α-Syn was upregulated and its aggregation was accelerated by S protein and N protein. It was noticed that SARS-CoV-2 proteins caused Lewy-like pathology in the presence of α-Syn overexpression. By confirming that SARS-CoV-2 proteins directly interact with α-Syn, our study offered new insights into the mechanism underlying the development of PD on the background of COVID-19.
Keywords: Parkinson’s disease; SARS-CoV-2; alpha-synuclein; nucleocapsid protein; spike protein.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
The effect of SARS-CoV-2 on the development of Parkinson's disease: the role of α-synuclein.Hum Cell. 2024 Jan;37(1):1-8. doi: 10.1007/s13577-023-00988-2. Epub 2023 Sep 21. Hum Cell. 2024. PMID: 37735344 Review.
-
SARS-CoV-2 Spike Protein S1 Domain Accelerates α-Synuclein Phosphorylation and Aggregation in Cellular Models of Synucleinopathy.Mol Neurobiol. 2024 Apr;61(4):2446-2458. doi: 10.1007/s12035-023-03726-9. Epub 2023 Oct 28. Mol Neurobiol. 2024. PMID: 37897633
-
Interactions between SARS-CoV-2 N-Protein and α-Synuclein Accelerate Amyloid Formation.ACS Chem Neurosci. 2022 Jan 5;13(1):143-150. doi: 10.1021/acschemneuro.1c00666. Epub 2021 Dec 3. ACS Chem Neurosci. 2022. PMID: 34860005 Free PMC article.
-
SARS-CoV-2-Mimicking Pseudoviral Particles Accelerate α-Synuclein Aggregation In Vitro.ACS Chem Neurosci. 2024 Jan 17;15(2):215-221. doi: 10.1021/acschemneuro.3c00468. Epub 2023 Dec 22. ACS Chem Neurosci. 2024. PMID: 38131609
-
α-Synuclein aggregation and transmission in Parkinson's disease: a link to mitochondria and lysosome.Sci China Life Sci. 2020 Dec;63(12):1850-1859. doi: 10.1007/s11427-020-1756-9. Epub 2020 Jul 15. Sci China Life Sci. 2020. PMID: 32681494 Review.
Cited by
-
Anti-Inflammatory and Neuroprotective Polyphenols Derived from the European Olive Tree, Olea europaea L., in Long COVID and Other Conditions Involving Cognitive Impairment.Int J Mol Sci. 2024 Oct 14;25(20):11040. doi: 10.3390/ijms252011040. Int J Mol Sci. 2024. PMID: 39456822 Free PMC article. Review.
-
Pathophysiology of COVID-19-Related Extrapyramidal Disorders.Adv Exp Med Biol. 2024;1457:111-123. doi: 10.1007/978-3-031-61939-7_6. Adv Exp Med Biol. 2024. PMID: 39283423 Review.
-
Phase Separation of SARS-CoV-2 Nucleocapsid Protein with TDP-43 Is Dependent on C-Terminus Domains.Int J Mol Sci. 2024 Aug 12;25(16):8779. doi: 10.3390/ijms25168779. Int J Mol Sci. 2024. PMID: 39201466 Free PMC article.
-
Sex-specific biphasic alpha-synuclein response and alterations of interneurons in a COVID-19 hamster model.EBioMedicine. 2024 Jul;105:105191. doi: 10.1016/j.ebiom.2024.105191. Epub 2024 Jun 11. EBioMedicine. 2024. PMID: 38865747 Free PMC article.
-
Environmental risk factors provoke new thinking for prevention and treatment of dementia with Lewy bodies.Heliyon. 2024 Apr 26;10(9):e30175. doi: 10.1016/j.heliyon.2024.e30175. eCollection 2024 May 15. Heliyon. 2024. PMID: 38707435 Free PMC article. Review.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
